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Pericytes are perivascular cells that envelop and make intimate connections with adjacent
capillary endothelial cells. Recent studies show that they may have a profound impact
in skeletal muscle regeneration, innervation, vessel formation, fibrosis, fat accumulation,
and ectopic bone formation throughout life. In this review, we summarize and evaluate
recent advances in our understanding of pericytes’ influence on adult skeletal muscle
pathophysiology. We also discuss how further elucidating their biology may offer new
approaches to the treatment of conditions characterized by muscle wasting.
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INTRODUCTION
In skeletal muscle, small blood vessels called capillaries sur-
round each myofiber (Poole et al., 2008). The capillary wall
consists of endothelial cells and pericytes. The latter are wrapped
by the capillary basal lamina, located on the abluminal surface
of the endothelial capillary tube. The word pericyte derives from
the Greek kytos, a hollow vessel, appropriately describing a cell
surrounding a blood vessel.
Electron microscopy studies estimated the pericyte-to-
endothelial-cell ratio for the overall coverage of microvessels
in striated skeletal muscle as approximately 1:100 (Shepro and
Morel, 1993). However, the analyzed samples were unstained, so
the technique could not precisely distinguish pericytes from other
surrounding cells. Pericytes are defined by their anatomical loca-
tion in combination with several molecular markers (Kunz et al.,
1994; Verbeek et al., 1994; Lindahl et al., 1997; Ozerdem et al.,
2001), and the great advances in fluorescent imaging techniques
suggest reanalyzing this ratio.
In most peripheral organs, pericytes are derived from the
mesoderm (Armulik et al., 2011), but their origin in skeletal
muscle has not been explored sufficiently. Specific pericyte sub-
populations with distinct roles in the skeletal muscle have been
described (Birbrair et al., 2013c). Whether pericyte subsets derive
from different embryonic tissues remains unknown. CNS peri-
cytes derive from the ectoderm (Bergwerff et al., 1998; Etchevers
et al., 2001; Korn et al., 2002; Heglind et al., 2005). Brain peri-
cytes exhibit both exclusive markers (Bondjers et al., 2006) and
markers shared with skeletal muscle pericytes (Armulik et al.,
2011). Whether and how pericyte functions in skeletal muscle
differ from those in the brain remains to be explored. Brain
and skeletal muscle pericytes express NG2 proteoglycan (Armulik
et al., 2011; Birbrair et al., 2013c) and react to injury by form-
ing fibrotic scars (Popa-Wagner et al., 2006; Dulauroy et al.,
2012), suggesting that, independent of location, they share some
properties.
Transplanting fluorescently marked embryonic tissues (e.g.,
mesoderm, endoderm, ectoderm, neural crest cells) into
unmarked embryonic skeletal muscle may provide some clues on
pericyte ancestors. Another approach would use transgenic mice
for genetic tracking of cells from different embryonic tissues to
pinpoint the origin of skeletal muscle pericytes and whether it dif-
fers for the recently identified subpopulations (Figure 1) (Birbrair
et al., 2013a,c,d, 2014, 2015).
Pericytes are heterogeneous, exhibiting major differences
depending on the tissue from which they have been isolated
(Sims, 2000; Bondjers et al., 2006). Their functions seem to
be tissue-specific, and very little is known about their func-
tion in skeletal muscle. Here, we present an overview of the
current knowledge on their participation in adult muscle regener-
ation, reinnervation, vascularization, fibrosis, fat formation, and
calcium deposition.
PERICYTE PARTICIPATION IN SKELETAL MUSCLE
REGENERATION
Skeletal muscle comprises about 40% of the human body by
weight. It is a highly organized network of different types of cells,
neurovascular structures, and connective tissue. It may undergo
physiological changes based on everyday physical activity, and
due to its superficial location, it is constantly subjected to dif-
ferent grades of traumatic injury. Nevertheless, in young healthy
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FIGURE 1 | Diagram depicting the roles of pericyte subtypes in skeletal
muscle. Type-1 (yellow) and type-2 (green) pericytes are associated with
blood vessels and differentially committed to tissue formation. Type-1
pericytes form adipose and fibrous tissue, while type-2 pericytes cooperate
with myogenesis and angiogenesis. Their role in muscle innervation and
ectopic bone deposition remains unexplored.
subjects, skeletal muscle is well recognized for its remarkably
robust endogenous capacity to repair itself (Huard et al., 2002;
Cossu and Biressi, 2005; Relaix and Zammit, 2012). Functional
loss of skeletal muscle mass and strength is observed with aging
in a process known as sarcopenia (Delbono, 2011); as a sec-
ondary effect, known as cachexia, in some cancer patients; and
due to trauma, vascular injuries, or degenerative muscle disor-
ders, such as muscular dystrophy (Janssen et al., 2002; Acharyya
et al., 2005; Glass, 2010; Vilquin et al., 2011). Muscle wasting
can cause severe debilitating weakness and represents a signifi-
cant clinical problem with few solutions (Vilquin et al., 2011). All
of these conditions would benefit from approaches that promote
skeletal muscle regeneration, but they would require complete
understanding of the complexity of the cellular mechanisms
involved.
The most well-studied myogenic cells in skeletal muscle are
the muscle-specific stem cells called satellite cells, which are
located between the basal lamina and sarcolemma of individ-
ual myofibers (Charge and Rudnicki, 2004; Zammit et al., 2006;
Boldrin and Morgan, 2013). These cells participate in skeletal
muscle repair in response to injury, but they are scarce and dif-
ficult to isolate (Berardi et al., 2014). Other problems include
poor survival, incompatibility with systemic delivery, and host
rejection (Giordano and Galderisi, 2010). Hence, researchers have
explored and identified other skeletal muscle cells with high myo-
genic potential. They include muscle-derived stem cells (MDSCs;
Lee et al., 2000; Qu-Petersen et al., 2002; Lavasani et al., 2006;
Urish et al., 2009; Drowley et al., 2010); CD133+ progenitor
cells (Torrente et al., 2004; Peault et al., 2007; Negroni et al.,
2009); endothelial cells (Zheng et al., 2007); PW1+ interstitial
cells (Mitchell et al., 2010; Pannerec et al., 2013); muscle side pop-
ulation (SP) cells (Gussoni et al., 1999; Asakura and Rudnicki,
2002; Bachrach et al., 2004); and pericytes (Dellavalle et al., 2007,
2011; Birbrair et al., 2013a,d).
Note that, besides cell therapy, all these cells may contribute
to endogenous skeletal muscle formation, defined as the creation
of new myofibers by proliferation, recruitment, migration and
fusion of mononucleated cells (Yin et al., 2013).
The exact relationship between the different skeletal muscle
cell types with myogenic potential and whether they all derive
from one source have yet to be established. Future studies must
define their specific contributions to muscle formation. One
approach might be to use mouse models in which only one of
these cell populations is ablated. Such a study showed that satellite
cells are essential for skeletal muscle regeneration (Lepper et al.,
2011; McCarthy et al., 2011; Murphy et al., 2011; Sambasivan
et al., 2011). However, efficient skeletal muscle formation also
depends on the interaction of cell types without myogenic poten-
tial, such as connective tissue fibroblasts (Barnes and Glass, 2011).
In future studies ablating each of these cell populations separately,
followed by skeletal muscle regeneration analysis, we may learn
that they interact physically and release factors directly affecting
each other’s myogenic capacity.
Pericytes are myogenic in vitro (Dellavalle et al., 2007). When
injected into injured skeletal muscle, they induce a higher mus-
cle regenerative index than enriched myoblasts (Crisan et al.,
2008b). Intra-arterial transplantation in animal models of mus-
cular dystrophies demonstrated that they largely engrafted and
may improve skeletal muscle function (Sampaolesi et al., 2003,
2006). Tedesco et al. (2012) found that transplantation of geneti-
cally modified pericytes resulted in functional amelioration of the
dystrophic phenotype.
A more interesting question is whether endogenous pericytes
contribute to skeletal muscle formation. Fate-tracking experi-
ments with alkaline phosphatase (AP) Cre-ER mice proved that
pericytes associated with blood vessels contribute to postna-
tal skeletal muscle growth by type; for example, less in tibialis
anterior than diaphragm. They can assume satellite cells’ posi-
tion and become satellite cells (Dellavalle et al., 2011). Through
unknown mechanisms, pericytes’ contribution increases greatly
during skeletal muscle regeneration in response to chemical
injury (Dellavalle et al., 2011). Whether pericytes expand in the
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skeletal muscle following physical injury (for instance, in response
to exercise) remains unknown; and, if so, whether the mecha-
nisms are similar to those activated in response to chemical injury
must be addressed (Boppart et al., 2013).
The molecular mechanisms activating and orchestrating peri-
cytes’ transition from quiescence to regenerating capacity in the
skeletal muscle are also unknown. Again, whether selective abla-
tion of pericytes from skeletal muscle will prevent or otherwise
affect regeneration will clarify whether they can be replaced by
other cell types with myogenic capacity. We propose that due
to their ability to secrete several growth factors, pericytes may
be required to induce other cell types to adopt a myogenic fate
(Sato and Rifkin, 1989; Shepro andMorel, 1993; Davis et al., 1996;
Yamagishi et al., 1999; Brown et al., 2001; Reinmuth et al., 2001;
Hirschi et al., 2003; Niimi, 2003; Armulik et al., 2005; Paquet-
Fifield et al., 2009; Shimizu et al., 2011). A global analysis of
candidate growth factors secreted by skeletal muscle pericytes that
promote skeletal muscle regeneration is required.
Our recent work reported the presence of two pericyte sub-
populations in the skeletal muscle. Type-1 (Nestin-GFP-/NG2-
DsRed+) and type-2 (Nestin-GFP+/NG2-DsRed+) pericytes are
in close proximity to blood vessel endothelial cells and co-localize
with other pericytic markers (Birbrair et al., 2013c), but only
type-2 is myogenic and participates in skeletal muscle regenera-
tion (Birbrair et al., 2013a). Type-1 may not express the specific
receptors needed to mediate the signaling pathways required for
myogenic differentiation. Future studies should reveal the spe-
cific signaling pathways and why only one subpopulation can be
induced to a myogenic fate. We also found that only type-2 peri-
cytes can enter the satellite cell compartment and express satellite
cell marker Pax7 (Birbrair et al., 2013d).
The host microenvironment is critical for their myogenicity;
for example, in older mice, the muscular regenerative capacity of
type-2 pericytes is limited (Birbrair et al., 2013d), suggesting that
it might be improved by modifying the deleterious aged mus-
cle microenvironment. Approaches aimed at changing the old
skeletal muscle environment have been reported. For instance, 3D
hydrogel was used to rejuvenate pericytes derived from aged skele-
tal muscle, and their myogenic capacity improved (Fuoco et al.,
2014).
To what extent impaired type-2 myogenicity leads to myofiber
loss or skeletal muscle atrophy as compared to the effects of other
myogenic cells in the skeletal muscle has yet to be defined. No
one has yet studied whether intrinsic pericyte changes may impair
skeletal muscle regeneration with aging, as recently reported in
satellite cells (Bentzinger and Rudnicki, 2014; Bernet et al., 2014;
Cosgrove et al., 2014; Sousa-Victor et al., 2014). Further, are per-
icyte autonomous changes with aging reversible? Is one pericyte
subtype more prone to senescence or apoptosis? Does the aging
environment select for a pericyte subtype with poorer myogenic
potential? Does the number of distinct pericyte subpopulations
change with aging and in diseased dystrophic skeletal muscle?
The only marker differentially expressed in skeletal muscle
pericytes is Nestin-GFP, which is also expressed in satellite cells
(Birbrair et al., 2011). Thus, only the combination of Nestin-GFP
and NG2-DsRed expression distinguishes the pericyte subpopu-
lations reported in the muscle interstitium (Birbrair et al., 2013c).
Future studies to determine whether the absence of endoge-
nous type-2 pericytes compromises skeletal muscle regeneration,
as with satellite cells (Barnes and Glass, 2011; Dellavalle et al.,
2011; Lepper et al., 2011; McCarthy et al., 2011), will require
discovery of novel markers selectively expressed in a pericyte
subpopulation. To define them, investigators must first character-
ize the expression profiles of type-1 and type-2 pericytes. Better
characterization may also advance therapies that target specific
receptors. For instance, β-agonist therapy has shown potential in
skeletal muscle repair (Beitzel et al., 2004); whether skeletal mus-
cle pericytes express beta adrenergic receptors in response to these
drugs is not known, although pericytes from other tissues do so
(Kelley et al., 1988; Elfont et al., 1989; Ferrari-Dileo et al., 1992;
Zschauer et al., 1996; Rucker et al., 2000; Quignard et al., 2003;
Mendez-Ferrer et al., 2010a,b; Daly andMcGrath, 2011; Lee et al.,
2014).
Recent studies demonstrate that pericytes are involved in skele-
tal muscle regeneration as described above (Crisan et al., 2008b;
Dellavalle et al., 2011; Birbrair et al., 2013a). However, the molec-
ular mechanisms underlying the recruitment of pericytes in this
complex process are unknown.
PERICYTES IN SKELETAL MUSCLE REINNERVATION
Muscle innervation is essential for maintaining mass and func-
tion with aging (Delbono, 2003, 2011). Denervation can result
from trauma, immobility, unloading, infections, vasculitis, neu-
ropathies, autoimmune processes, neoplasms, amyotrophic lat-
eral sclerosis, and aging (Polak et al., 1988; Nikawa et al., 2004;
Argiles et al., 2006; Glass, 2010; Bonaldo and Sandri, 2013).
Loss of the nerve supply causes robust progressive skeletal mus-
cle degeneration (Nikawa et al., 2004; Batt et al., 2006; Aagaard
et al., 2010; Ohlendieck, 2011). Focal injuries to the peripheral
nerves are often followed by complete recovery due to the capac-
ity of peripheral axons to reoccupy neuromuscular junctions
on denervated muscle fibers (Young, 1974; Rich and Lichtman,
1989; Nguyen et al., 2002). Even without nerve injury, the nerve
terminal is constantly remodeled during degeneration and regen-
eration of skeletal muscle fibers, as this neuromuscular connec-
tion is needed for functional recovery of skeletal muscle (Li
and Thompson, 2011). Rounds of denervation and reinnerva-
tion are evidenced by the random distribution of myofiber types
across the skeletal muscle and their increased clustering with
age (Larsson, 1995; Andersen, 2003; Rowan et al., 2012). Over
the years, complete functional recovery is significantly reduced
(Verdu et al., 2000; Kawabuchi et al., 2011). Whether these
changes are controlled by the muscular, neural, or both systems
is not known. Myofiber denervation has been demonstrated in
mice and elderly humans (Hashizume et al., 1988; Kanda and
Hashizume, 1989, 1992; Einsiedel and Luff, 1992; Doherty et al.,
1993; Johnson et al., 1995; Zhang et al., 1996; Delbono, 2003;
Aagaard et al., 2010; Valdez et al., 2010; Chai et al., 2011).
Regenerating axons grow through a complex microenviron-
ment during the reinnervation process (Rich and Lichtman,
1989). They probably recognize and attach to postsynaptic sites
guided by non-synaptic muscle fiber membranes and the mem-
branes of glial cell processes (Kang et al., 2007). Schwann cells
are widely believed to support axonal growth and to provide
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important cues that enable nerve fibers to reach the vacant synap-
tic sites (Chen et al., 2007). They also provide such important
growth factors as neurotrophins, which ensure correct reinnerva-
tion after experimental nerve transection (Sendtner et al., 1992;
Funakoshi et al., 1993; Friedman et al., 1996; Frostick et al., 1998;
Brushart et al., 2013). Regenerating axons are guided by processes
extended by terminal Schwann cells at the denervated synaptic
location (Kang et al., 2014). Distinct Schwann cell populations
have been described, including non-myelinating, myelinating,
terminal, and perisynaptic Schwann cells, and terminal Schwann-
like cells of sensory neuritis (Kwan, 2013). How their roles differ
in skeletal muscle reinnervation remains poorly understood. The
release of neurotrophic factors may be differentially regulated in
these subpopulations. Schwann cells from young and old mice
have been shown to differ both morphologically and in their abil-
ity to cover the motor endplate (Chai et al., 2011). The number of
cells at the neuromuscular junction increases after skeletal mus-
cle denervation, and based on Schwann cell markers, not all are
Schwann cells (Magill et al., 2007). Future studies should deter-
mine the identity of the other cells and how they contribute
to reinnervation. Whether pericytes participate remains largely
unexplored.
Previous studies have demonstrated that CNS perivascular
pericytes can form cells that express glial markers (Dore-Duffy
et al., 2006; Bonkowski et al., 2011; Jung et al., 2011; Nakagomi
et al., 2011). In skeletal muscle, cells in the interstitial space differ-
entiate into glial lineage (Romero-Ramos et al., 2002; Alessandri
et al., 2004; Kondo et al., 2006; Schultz and Lucas, 2006; Arsic
et al., 2008; Birbrair et al., 2011). We recently demonstrated that
under optimized skeletal muscle culture conditions, only type-
2 pericytes form oligodendrocyte progenitors (Birbrair et al.,
2013b,c), which produce mature oligodendrocytes and Schwann
cells (Zawadzka et al., 2010). Whether type-2 pericytes contribute
to Schwann cell populations generally and to the newly formed
Schwann cells that participate in skeletal muscle reinnervation
specifically remains to be addressed.
Also, to what degree do these endogenous pericytes influence
the reoccupation of synaptic sites during reinnervation? Recently,
cells isolated from adult human skeletal muscle were shown to
differentiate into myelinating Schwann cells and to ameliorate a
critical-sized sciatic nerve injury in a murine model. Denervated
skeletal muscles from treated mice exhibit substantially decreased
atrophy, and the motor endplates at the postsynaptic sites reorga-
nize (Lavasani et al., 2014). Although this study provides evidence
for the therapeutic capability of skeletal muscle-derived cells
in vivo, it did not identify these cells. As the skeletal muscle
cell environment is heterogenous, future work should focus on
identifying muscle-derived cells that can repair the sciatic nerve
after injury. We reported that only type-2 pericytes have gliogenic
potential in the skeletal muscle (Birbrair et al., 2013c), so they
are immediate candidates for testing. Tracking pericyte fate by
an inducible Cre system after skeletal muscle denervation will be
required to address pericyte potential to form Schwann cells.
As there are several types of Schwann cells (Kwan, 2013), it
would be interesting to explore whether pericytes form a spe-
cific subtype. TheWnt/beta-catenin signaling pathway is active in
NG2+ cells differentiating into NG2 glia cells in the brain (White
et al., 2010). As pericytes express NG2 proteoglycan and form
NG2 glia cells (Birbrair et al., 2013b,c), this pathway might be
activated to induce skeletal muscle reinnervation.
To understand the role of pericytes in neuromuscular junc-
tion regeneration, future studies should test the effect of ablating
them after sciatic nerve injury. Mouse models using viral thymi-
dine kinase to genetically deplete pericytes are viable and have
been used recently (Cooke et al., 2012; Lebleu et al., 2013). As
Schwann cells have the capacity to dedifferentiate into immature
cells after sciatic nerve injury (Yang et al., 2012), do they ever
become pericytes?
We envision that determining exactly what happens after den-
ervation may provide cellular targets for pharmacological manip-
ulation to improve skeletal muscle reinnervation. At present, the
role of pericytes in this process is only speculative.
PERICYTE CONTRIBUTION TO VESSEL FORMATION IN
SKELETAL MUSCLE
Blood supply to the skeletal muscle can be compromised after
vascular injury, bone fracture, and crush injury (Blaisdell, 2002)
and by complications due to such cardiovascular and metabolic
diseases as atherosclerosis, heart failure, diabetes, and obesity
(Baumgartner et al., 2005; Varu et al., 2010; Chi et al., 2011). In
addition, the number of capillaries and arteries feeding the skele-
tal muscle decreases with age (Conley et al., 2000; Behnke et al.,
2006), compromising its perfusion (Wahren et al., 1974; Irion
et al., 1987). Compared to young mice, the capacity of old mice to
form new blood vessels (angiogenesis) is impaired (Rivard et al.,
1999; Shimada et al., 2004; Yu et al., 2006).
When the blood supply to tissue is partially obstructed, oxy-
gen content decreases, leading to ischemia (Forsythe et al., 1996;
Heil and Schaper, 2004). Collateral arteries and anastomoses can
partially restore blood flow (Heil and Schaper, 2004), attenuat-
ing the damage caused by hypoxia, but even short-term ischemia
induces necrosis, leading to inflammatory reactions. After only
5 h, an ischemic environment causes necrosis in 90 percent of
skeletal muscle (Labbe et al., 1987). If revascularization fails, it
can lead to limb amputation (Conrad et al., 2011). While exercise
is a potent stimulus for new vessel formation in adult skele-
tal muscle (Booth and Thomason, 1991; Egginton, 2009), most
of the conditions leading to skeletal muscle ischemia preclude
exercise.
Angiogenesis is a complex process in which new blood vessels
form from existing ones. It involves extensive interplay between
cells and growth factors, extracellular matrix proteins, proteases,
and adhesion molecules (Folkman, 1971; Caduff et al., 1986;
Kilarski et al., 2009). The exact cellular mechanisms of physiolog-
ical angiogenesis in skeletal muscle remain poorly understood. It
requires the proliferation andmigration of endothelial cells to line
the interior of the blood vessels (Rousseau et al., 2000; Li et al.,
2005; Lamalice et al., 2006). Macrophages and other inflamma-
tory cells (Barbera-Guillem et al., 2002; Shireman, 2007) infiltrate
the tissues after ischemia (Sica, 2010; Alexander et al., 2011) and,
together with fibroblasts and myofibers (Gustafsson et al., 1999;
Steinbrech et al., 1999), secrete such angiogenic molecules as vas-
cular endothelial growth factor (VEGF), placenta growth factor
(PlGF), fibroblast growth factor 2 (FGF2), and platelet-derived
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growth factor (PDGF; Lewis and Murdoch, 2005; Murdoch and
Lewis, 2005; Murdoch et al., 2005), which are necessary to
construct new blood vessels and to restore blood perfusion.
Pericytes also participate in the formation of new blood ves-
sels (Egginton et al., 1996; Hellstrom et al., 1999; Gerhardt
and Betsholtz, 2003; Bergers and Song, 2005). This partici-
pation includes phenotype changes, migration, alignment, and
contacts with endothelial cells. Pericytes are the first cells to
invade newly vascularized tissues (Diaz-Flores et al., 1991; Nehls
et al., 1992; Reynolds et al., 2000). The hypoxic state stimu-
lates pericyte migration and angiogenesis (Murata et al., 1994).
They adopt angiogenic phenotype by shortening their processes
and increasing their somatic volume (Diaz-Flores et al., 1992b,
1994b). Autoradiographic studies show that the proliferation of
these activated pericytes increases (Schoefl, 1963; Cavallo et al.,
1972, 1973; Sholley et al., 1977; Burger and Klintworth, 1981;
Diaz-Flores et al., 1992b, 1994a,b). Pericytes guide and deter-
mine where the newly formed blood vessels spread (Nehls et al.,
1992; Tsuzuki and Sasa, 1994; Ozerdem et al., 2001; Morikawa
et al., 2002; Ozerdem and Stallcup, 2003) and promote endothe-
lial cell survival (Amselgruber et al., 1999; Morikawa et al.,
2002; Darland et al., 2003; Kale et al., 2005). They can form
tubes (Moldovan et al., 2000; Anghelina et al., 2002, 2004, 2006;
Ozerdem and Stallcup, 2003) and penetrate endothelial cells.
They prevent vessel regression (Benjamin et al., 1998, 1999; Enge
et al., 2002). Pericytes express PDGF receptors and respond to
PDGF (Balabanov et al., 1996). Their recruitment is crucial for
vessel maturation, as the lack of PDGF disrupts vessel develop-
ment (Lindahl et al., 1997; Hellstrom et al., 2001). Following
exercise, NF-κB, a strong inducer of angiogenesis, is activated in
a pericyte sub-population (Hyldahl et al., 2011). Under hypoxic
conditions, VEGF from pericytes can stimulate other pericytes to
proliferate and migrate (Yamagishi et al., 1999).
The process of angiogenesis depends on appropriate cell sig-
naling based in the tissue microenvironment, so most of our data
comes from in vivo studies. Dissecting and occluding the femoral
artery to induce brief ischemia is a common model for study-
ing physiological angiogenesis (Shireman and Quinones, 2005;
Westvik et al., 2009).
Therapeutic angiogenesis has been pursued as a potential
treatment for ischemic disorders (Isner and Asahara, 1999;
Ferrara and Kerbel, 2005; Giacca and Zacchigna, 2012). Its goal
is to stimulate blood vessels to grow new blood vessels (Folkman,
1995; Isner, 1996; Ferrara and Kerbel, 2005). Several cell types
have been used to induce neovascularization (Kalka et al., 2000;
Hamano et al., 2001; Shintani et al., 2001; Iwase et al., 2005;
Swijnenburg et al., 2005). Pericyte transplantation induces angio-
genesis and improves blood flow to ischemic hindlimbs in animal
models (He et al., 2010; Dar et al., 2012), and based on their
role in forming and stabilizing engineered blood vessels, they
have been proposed for angiogenic therapy. Surprisingly, not all
pericytes can induce angiogenesis. Only type-2 has angiogenic
potential in vitro, and, in vivo, angiogenesis occurs when type-
2, but not type-1, pericytes are injected with endothelial cells in
a Matrigel plug (Birbrair et al., 2014). Type-2 can also recover
blood flow in amousemodel of hindlimb ischemia (Birbrair et al.,
2014), but the mechanism remains to be elucidated (Birbrair
et al., 2014). Due to the short recovery time, the femoral artery
is probably rebuilt by anastomoses of the proximal stump with
new collateral blood vessels after intramuscular pericyte injection
(Schaper and Scholz, 2003).
Pericyte subtypes in human skeletal muscle have not yet been
identified and isolated, and whether their angiogenic potential
differs remains unknown.
To study the physiological roles of different cell populations,
genetic strategies to ablate specific cell types have been devel-
oped. Several transgenic mice now provide effective means to
genetically ablate pericytes (Cooke et al., 2012; Lebleu et al.,
2013), satellite cells (Dellavalle et al., 2011; Lepper et al., 2011;
McCarthy et al., 2011), fibroblasts (Barnes and Glass, 2011), and
macrophages (Ferenbach et al., 2012; Weisser et al., 2012) for a
defined period. These studies will elucidate the exact role of each
cell population in inducing and regulating skeletal muscle angio-
genesis. For example, to determine whether endogenous pericytes
are necessary for skeletal muscle angiogenesis after ischemia,
transgenic mice with pericyte depletion, such as NG2-tk (Cooke
et al., 2012; Lebleu et al., 2013), should be examined. Cell abla-
tion studies must consider that besides pericytes, oligodendrocyte
progenitors express NG2 (Encinas et al., 2011).
Understanding the molecular mechanisms of ischemia
induced endogenous angiogenesis is critical. Genetically modi-
fied mice have been widely applied to study the signals required
for postnatal hindlimb angiogenesis. Knockout mice allowed
several groups to test whether such signals are necessary for
skeletal muscle angiogenesis. Neovascularization of impaired
ischemic limbs was found in mice deficient in angiotensin
II type-1 receptor (Sasaki et al., 2002), endothelial-derived
nitric oxide synthase (eNOS; Murohara et al., 1998), matrix
metalloproteinase-9 (Johnson et al., 2004), caveolin-1 (Sonveaux
et al., 2004), adiponectin (Shibata et al., 2004), PlGF (Carmeliet
et al., 2001), and IL-10 (Silvestre et al., 2000). Are these molecules
expressed in pericytes? The specific cell types essential to angio-
genesis after hindlimb ischemia remain unclear. In addition,
analysis of global knockout mutant mice is complicated by
unrelated side effects in other tissues, which can be avoided only
by performing conditional mutagenesis. When investigators can
control the timing and location of somatic mutations in adult
mice, they will be able to determine the roles of specific signaling
molecules in different cell populations and the functional con-
sequences of deleting single genes in specific cell types, such as
pericytes, during skeletal muscle angiogenesis. The clinical need
for interventions in ischemic illnesses leading to revascularization
and the encouraging recent findings that pericytes have the
potential to improve blood perfusion will stimulate these efforts.
PERICYTES IN SKELETAL MUSCLE FIBROSIS
Fibrosis is an incompletely understood process characterized by
excessive accumulation of extracellular matrix components, such
as collagen (Wynn, 2008). It occurs under chronic disease con-
ditions and may affect skeletal muscle (Wynn, 2007). Fibrous
tissue may prevent full functional recovery of skeletal muscle
(Kasemkijwattana et al., 1998; Kaariainen et al., 2000; Huard
et al., 2002; Jarvinen et al., 2005; Gharaibeh et al., 2012), which,
under normal conditions, can repair itself after injury. Fibrosis
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directly contributes to progressive skeletal muscle dysfunction in
several chronic diseases, such as Duchenne muscular dystrophy
(Mann et al., 2011; Brandan and Gutierrez, 2013; Morales et al.,
2013; Acuna et al., 2014); and its treatment is currently con-
sidered important for muscular dystrophies. Furthermore, one
of the causes of age-related skeletal muscle stiffness, weakness,
and atrophy is increased infiltration of fibrous tissue (Ryall et al.,
2008; Thompson, 2009; Kragstrup et al., 2011; Walston, 2012).
The regenerative potential of muscle stem cells is limited by the
formation of fibrous tissue, which lacks innervation and contrac-
tile properties (Juhas and Bursac, 2013). Studies performed in
mouse models clearly associate skeletal muscle fibrosis with aging
(Goldspink et al., 1994; Huard et al., 2002; Jarvinen et al., 2002;
Brack et al., 2007; Zhu et al., 2007; Graham et al., 2010; Trensz
et al., 2010). Understanding the cellular and molecular mecha-
nisms underlying skeletal muscle fibrosis is essential to developing
effective antifibrotic therapies.
While collagen accumulation is a major feature of skeletal
muscle fibrosis (Mohan and Radha, 1980; Alnaqeeb et al., 1984;
Goldspink et al., 1994; Haus et al., 2007; Kragstrup et al., 2011),
the source of the collagen-producing cells in various conditions
is less clear. Many have been proposed, including resident fibrob-
lasts (Thiery et al., 2009; Lieber and Ward, 2013), muscle-derived
stem cells (Li and Huard, 2002), myoblasts (Li et al., 2004;
Alexakis et al., 2007), endothelial cells (Zeisberg et al., 2007), per-
icytes (Birbrair et al., 2013d), fibroadipogenic progenitors (FAPs;
Joe et al., 2010; Uezumi et al., 2011), fibrocytes (Herzog and
Bucala, 2010), and even nerve-associated cells (Hinz et al., 2012).
However, the exact role of these cells in skeletal muscle fibrosis is
unclear, and the origin of collagen-producing cells has not been
confirmed using the same methodologies (in vitro or in vivo).
Furthermore, skeletal muscle fibrosis induced in different ways
may recruit different cell populations. For instance, some fibro-
sis mouse models are reversible, and collagen production may
be part of the repair process. Given the large number of possi-
ble cell sources, future studies will have to use modern molecular
techniques, such as fate-mapping, to create strategies to reverse
skeletal muscle fibrosis.
Chronic activation of PDGFRα results in widespread organ
fibrosis (Olson and Soriano, 2009), indicating that PDGFRα+
cells may have a role in skeletal muscle fibrosis. Type-1 peri-
cytes and FAPs express this receptor (Joe et al., 2010; Uezumi
et al., 2010, 2011; Birbrair et al., 2013a), and like pericytes, FAPs
line the skeletal muscle vasculature (Joe et al., 2010), suggest-
ing their roles may overlap (Birbrair et al., 2013a). The extent
of perivascular PDGFRα+ cells’ contribution to skeletal mus-
cle fibrosis has not been demonstrated. Future studies should
use fate-mapping of endogenous skeletal muscle PDGFRα+ cells
exposed to distinct conditions leading to fibrosis. Determining
whether PDGFRα+ pericytes and PDGFRα+ FAPs are lineage-
related and whether their roles in skeletal muscle fibrosis vary
would also be interesting.
As with PDGFRα, the selective overexpression of a disinte-
grin and metalloprotease 12 (ADAM12) in the skeletal mus-
cle increases fibrosis and suppresses regeneration (Jorgensen
et al., 2007). In an elegant study, researchers used an inducible,
tetracycline-dependent, cell-fate mapping system. They generated
triple transgenic mice that expressed tetracycline transactivator
under control of the ADAM12 locus, the conditional reporter
RosaYFP, and the recombinase Cre under control of the tetracy-
cline transactivator. Labeling the cells derived from ADAM12+
cells was temporally controlled by administering doxycycline,
which prevents Cre expression, and they inducibled genetic abla-
tion of ADAM12+ cells in the skeletal muscle. Their findings
revealed that pericytes expressing ADAM12 during development,
located in very close proximity to blood vessel endothelial cells,
give rise to most of the collagen-producing cells during skeletal
muscle injury (Dulauroy et al., 2012). However, fibrosis forma-
tion was analyzed in healthy, young skeletal muscle after injury.
Future studies should explore whether the collagen-producing
cells in the skeletal muscle of mdx and old mice have the same
ancestors.
A new finding complements the evidence that pericytes are the
source of collagen-producing cells in the fibrous tissue deposited
in old skeletal muscle. Birbrair et al. (2013d) found that the peri-
cytes involved in scar formation in the skeletal muscle of old mice
differ from those associated with skeletal muscle regeneration;
only type-1 pericytes contribute (Birbrair et al., 2013d). Future
studies should use this pericyte subpopulation as a cellular target
to reduce fibrosis in older mammals.
The cellular source of fibrosis in chronic diseases, such as
Duchenne muscular dystrophy, remains unknown. To what
extent type-1 pericytes contribute to collagen-producing cells in
the skeletal muscle in comparison with other cell populations that
give rise to those cells is also unclear. The detailed fate-mapping
and lineage-tracing experiments that confirm pericyte partici-
pation in skeletal muscle fibrosis have not been done for other
possible cellular sources of collagen-producing cells.
The basic molecular mechanisms involved in fibrous tissue
deposition in the skeletal muscle are not completely understood.
The well-studied cytokine transforming growth factor β (TGFβ),
which is released from injured myofibers, seems to be essential to
fibrous tissue formation (Massague, 2012). It binds to transmem-
brane receptor TGFβ receptor type II, recruiting TGFβ receptor
type I to the complex. Both receptors have serine/threonine
kinase activity and form heteromeric complexes in the pres-
ence of the activated ligand. TGFβ binding to the extracellular
domains of type I and type II receptors initiates signaling cascades
across the cell membrane by inducing transphosphorylation. It
subsequently activates the type I receptor at the glycine/serine
(GS)-rich domain, which acts as a phosphorylation site with
receptor kinase activity (Kang et al., 2009). The type 1 receptor
then catalyzes activation of the intracellular SMAD transcrip-
tion factors (Massague et al., 2005), which stimulate transcription
of specific target genes, leading to the production of extracel-
lular matrix proteins and fibrosis formation (Lieber and Ward,
2013) that interfere with skeletal muscle regeneration and func-
tion (Gharaibeh et al., 2012). In contrast, inhibiting TGFβ reduces
fibrosis and promotes muscle regeneration (Fukushima et al.,
2001; Sato et al., 2003).
TGFβ is involved in a range of biological processes (Heldin
et al., 2009; Padua and Massague, 2009; Hawinkels and Ten
Dijke, 2011; Dooley and Ten Dijke, 2012; Pardali and Ten Dijke,
2012). Thus, detailed understanding of which cells respond to
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its signaling is required for the design of effective therapeutic
approaches without undesirable side effects. At least in vitro,
type-1 pericytes respond to TGFβ, increasing type I collagen pro-
duction (Birbrair et al., 2013d), while type-2 did not seem to
respond under the same conditions (Birbrair et al., 2013d). Future
experiments should test whether TGFβ signaling is required for
pericytes to participate in skeletal muscle scarring in vivo. One
indication for this requirement is that TGFβ induces ADAM12
expression (Solomon et al., 2010; Dulauroy et al., 2012), which
plays an important role in pericytes’ fibrotic response.
Another member of the TGFβ protein superfamily, myostatin
(McPherron et al., 1997), also known as GDF-8, not only con-
trols skeletal muscle growth, but also regulates the progression of
fibrosis (Li et al., 2008). Connective tissue growth factor (CTGF)
is another molecule that has been shown to reproduce many of
the profibrotic effects of TGFβ in skeletal muscle. Elevated levels
of CTGF have been detected in skeletal muscle from mdx mice,
dystrophic dogs, and patients with Duchenne muscular dystro-
phy (Sun et al., 2008; Vial et al., 2008). Whether pericytes express
receptors and respond to myostatin and CTGF has yet to be
explored. TGFβ can also induce production of PDGFs (Bonner,
2004). As pericytes express receptors to these ligands (Hellstrom
et al., 1999), whether this signaling pathway plays a role in skeletal
muscle fibrosis in vivo should be explored. Fibroblasts that express
MMP9 and PlGF help to recover the vascular network struc-
ture by diminishing collagen deposition in the skeletal muscle of
old dystrophic mice (Gargioli et al., 2008). Whether the expres-
sion of these factors differs between the two pericyte subtypes is
unknown.
For full functional recovery of skeletal muscle affected by
chronic diseases, aging, and trauma, fibrosis must be limited.
Effective repair of skeletal muscle under these conditions cannot
be achieved yet. More studies are needed to define the cellular and
molecular mechanisms and functional significance of fibrosis in
healthy, young and diseased, old skeletal muscles. Although peri-
cytes play an important role in this process, detailed fate-mapping
and lineage-tracing experiments would significantly advance the
field.
PERICYTE CONTRIBUTION TO FAT ACCUMULATION IN
SKELETAL MUSCLE
Accumulation of ectopic adipocytes in skeletal muscle is typi-
cal of such disorders as obesity, sarcopenia, and dystrophies and
provides an accurate assessment of the severity of Duchennemus-
cular dystrophy (DMD) (Wren et al., 2008). Increased fat is also
observed in the skeletal muscle of older adults (Goodpaster et al.,
2004; Goodpaster and Wolf, 2004; Visser et al., 2005).
The origin of these fat cells has been revealed only recently.
A group of cells in the perimysium, particularly the perivascular
space (Greco et al., 2002), where fat accumulation is most evident,
express platelet-derived growth factor receptor α (PDGFRα), the
major contributor to ectopic fat cell formation in skeletal muscle.
These cells are quiescent in intact muscle but proliferate efficiently
in response to damage. PDGFRα+ cells differ from satellite cells
and are located in the muscle interstitial space betweenmyofibers,
close to blood vessels (Joe et al., 2010; Rodeheffer, 2010; Uezumi
et al., 2010). Skeletal muscle pericytes can differentiate in vitro
toward adipogenic lineage (Farrington-Rock et al., 2004; Crisan
et al., 2008a) but, like PDGFRα+ cells, do not generate myofibers,
and only type-1 express PDGFRα. When purified type-1 pericytes
are delivered intramuscularly in a mouse model of fatty infiltra-
tion, ectopic white fat is generated (Birbrair et al., 2013a). This
approach clearly identifies their adipogenic potential, but only
lineage-tracing will demonstrate that type-1 pericytes become fat
cells in skeletal muscle in vivo under physiological conditions.
Whether perivascular PDGFRα+ cells have a physiological
role in the various illnesses characterized by muscular ectopic
fat accumulation, such as myopathies and obesity, and whether
modifying cell properties by manipulation and grafting would
influence their fate in vivo are unclear. Although genetic trac-
ing techniques were used to track these cells in other tissues (Lee
and Granneman, 2012), confirming their capacity to become fat
cells in skeletal muscle will require lineage-tracing studies. Testing
whether depleting specific PDGFRα+ perivascular cells would
prevent fat formation in skeletal muscle would also be interesting.
Is activating PDGFRα important for the adipogenetic role
of PDGFRα+ perivascular cells in skeletal muscle? Most of the
primary functions of PDGFα and platelet-derived growth fac-
tor receptor α (PDGFRα), were unknown because Pdgfa and
Pdgfra knockout mice die either as embryos or shortly after birth.
Recent experiments using conditional gene ablation and gain-of-
function transgenics (Gnessi et al., 1993; Bostrom et al., 1996;
Soriano, 1997; Fruttiger et al., 1999; Karlsson et al., 1999, 2000)
showed that PDGFα receptors are crucial for the proper devel-
opment of several tissues (Crosby et al., 1998; Bostrom et al.,
2002; Ostman, 2004). After ligand binding, the kinase domains of
PDGFRα phosphorylate tyrosine residues of the receptor’s cyto-
plasmic domain, which act as docking sites for phosphatidylinos-
itol 3-kinase, STATs, SRC family kinases, SHP2 phosphatase, and
phospholipase Cγ (Vignais and Gilman, 1999; Lakner et al., 2010;
Xiong et al., 2010; Lin et al., 2014). These pathways regulate such
transcription factors as SREBP, FOXO, c-MYC, and AP1, which
are involved in cell growth, proliferation, differentiation, survival,
and migration (Besancon et al., 1998; Tsatsanis and Spandidos,
2000; Guida et al., 2007; Erovic et al., 2012). They have also been
linked to diseases characterized by fat accumulation in blood
vessel walls, such as atherosclerosis (Tedgui and Mallat, 2006;
Artwohl et al., 2009; Feinberg, 2013; Li et al., 2013). However,
the function of PDGFα ligands and their receptors in skeletal
muscle adipogenesis remains unclear. The pericyte marker neu-
ral/glial antigen 2 (NG2) proteoglycan (Ozerdem et al., 2001)
binds to PDGFα (Goretzki et al., 2000) and may function as its
co-receptor with a potential effect on the respective cell-surface
signaling receptor (PDGFRα) (Grako and Stallcup, 1995; Grako
et al., 1999). Future studies may determine whether the fate of
PDGFRα+ pericytes changes when they are exposed to PDGFα
and whether their differentiation potential remains unchanged
after exposure to PDGFRα-Fc chimeric receptors, which com-
pete with their receptors for ligands in vitro. Loss-of-function
and gain-of-function assays may demonstrate whether PDGFRα
in pericytes regulates fat formation in skeletal muscle.
Systemic factors, such as hormone levels and nutrients, may
play a role in regulating PDGFRα+ cells’ adipogenic poten-
tial. For instance, a high-glucose medium was reported to
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enhance adipogenic differentiation of skeletal muscle-derived
cells (Aguiari et al., 2008), suggesting that the microenvironment
may determine the fate of cells that sense changes in skeletal mus-
cle physiology. The ability to target skeletal muscle PDGFRα+
perivascular cells exclusively will open new therapeutic strategies
for skeletal muscle diseases caused by, or associated with, severe
adipose tissue accumulation.
Pericyte participation in fat infiltration of skeletal muscle
has been confirmed (Birbrair et al., 2013a), providing a cellular
target susceptible to pharmacological modulation and signaling
manipulation. This strategy will require more detailed analyses.
PERICYTES AND ECTOPIC BONE FORMATION IN SKELETAL
MUSCLE
Heterotopic ossification, the ectopic formation of bone and/or
cartilage in soft tissues, such as skeletal muscles outside the
periosteum, happens only in genetic disorders, such as fibrodys-
plasia ossificans progressiva and progressive osseous heteroplasia
(Adegbite et al., 2008; Yu et al., 2008; Kaplan et al., 2012). In
the skeletal muscles of mdx mice (dystrophin-deficient mouse
model of Duchenne muscular dystrophy) (Kikkawa et al., 2009;
Mu et al., 2013), this debilitating condition may be induced
by the inflammation associated with trauma. However, other
causes have been reported (Thorseth, 1968; Sirvanci et al., 2004;
McCulloch and Bush-Joseph, 2006; Bek et al., 2009; Kim and
Choi, 2009; Chouhan et al., 2012; Kalenderer et al., 2012).
The biological mechanism leading to osteoinduction in the
skeletal muscle under physiological conditions has not been iden-
tified, and the exact cellular origin of heterotopic ossification is
not well characterized. Nevertheless, recent sophisticated stud-
ies have made advances. The use of Cre/loxP technology allows
investigators to track specific cell lineages (Liu et al., 2004; Maes
et al., 2010). Several studies used murine models harboring
real-time visual transgenes and Cre/loxP technology as a pow-
erful way to identify which cells in skeletal muscle give rise to
bone-forming cells (Kan et al., 2009, 2013; Lounev et al., 2009;
Medici et al., 2010; Chakkalakal et al., 2012). Injury may pro-
voke a local inflammatory reaction, and cytokines released into
the blood might prompt circulating immune cells to differen-
tiate into osteoblasts. However, using CD19-Cre, LCK-Cre, and
Lyz-Cre transgenic mice, researchers have shown that B cells, T
cells, and macrophages/monocytes, respectively, do not generate
them (Kan et al., 2009). Somite-derived cells were excluded using
Nestin-Cre reporter mice, and myoblasts, which are more com-
mitted to the myogenic lineage, were excluded using Myf5-Cre
(Kan et al., 2009) and MyoD-Cre (Lounev et al., 2009) transgenic
mice. These results are consistent with the fact that, during the
generation of ectopic bone, the early immune response in skeletal
muscle lesions kills myoblasts (Shore and Kaplan, 2010).
Recent investigations have suggested that cells residing in
the skeletal muscle interstitial space contribute to some of the
ectopic bone tissue (Wosczyna et al., 2012). However, their pre-
cise identity was not determined (Bosch et al., 2000). Histological
analyses of heterotopic lesions from patients with fibrodys-
plasia ossificans progressiva demonstrate positive staining for
endothelial markers, such as the angiopoietin receptor, Tie2, in
ectopic chondrocytes and osteoblasts, suggesting a possible role
for endothelial cells (Lounev et al., 2009; Medici et al., 2010).
However, this marker is not specific to endothelial cells; in fact,
it is also expressed in pericytes (Park et al., 2003; Cai et al., 2008).
Cells expressing Tie2 receptor respond to inflammatory triggers,
differentiate into osteogenic lineage, and contribute greatly to
heterotopic bone in animal models of fibrodysplasia ossificans
progressiva (Lounev et al., 2009; Wosczyna et al., 2012). Lineage-
tracing studies using Tie2-Cre reporter mice have also pointed to
these cells in generating the chondrocytes and osteoblasts found
in skeletal muscle lesions (Lounev et al., 2009; Medici et al., 2010;
Chakkalakal et al., 2012). Other analyses revealed that skeletal
muscle osteogenic progenitors, distinct from satellite cells, express
PDGFRα (Oishi et al., 2013). They undergo osteogenic differ-
entiation both in vitro and in vivo in response to osteogenic
conditions and/or BMP stimuli (Uezumi et al., 2010; Oishi et al.,
2013) and have been observed surrounding ectopic bone tissues
after trauma in humans. In skeletal muscle, PDGFRα+ cells accu-
mulate around blood vessels (Uezumi et al., 2014) and include
type-1 pericytes (Birbrair et al., 2013a), suggesting that a peri-
cyte subpopulationmay also form ectopic bone in skeletal muscle.
Blood vessels could be a source of osteogenic progenitor cells,
which differentiate into osteoblasts, for example, when inflam-
matory cytokines are released by macrophages. However, this
hypothesis has not been tested experimentally.
Skeletal muscle pericytes have chondrogenic potential in vitro
(Crisan et al., 2008a), and Li et al. (2011) showed that cells resid-
ing in the skeletal muscle fascia have strong chondrogenic poten-
tial but lack pericyte marker CD146. Crisan et al. (2008b) also
reported that vascular pericytes may differentiate into osteoblasts.
Levy et al. (2001) and other groups suggested a similarity between
osteoprogenitors in the skeletal muscle and pericytes isolated
from intramuscular connective tissue (Diaz-Flores et al., 1992a;
Gronthos and Simmons, 1996; Reilly et al., 1998; Kuznetsov
et al., 2001; Levy et al., 2001; Crisan et al., 2008a). Whether they
contribute to the heterotopic ossification that occurs in skeletal
muscle in vivo is not known Although in bone marrow pericytes
are capable of bone formation (Shi and Gronthos, 2003; Sacchetti
et al., 2007; Mendez-Ferrer et al., 2010b), their characteristics may
vary significantly between tissues (Armulik et al., 2011).
A recent lineage-tracing study using GLAST-CreERmice iden-
tified GLAST-expressing cells as precursors that contribute to
heterotopic ossification (Kan et al., 2013). GLAST (glutamate
aspartate transporter) is expressed in various central nervous sys-
tem (CNS) cells, such as Muller, Bergmann glia, astrocyte, and
neural stem cells (Danbolt et al., 1992; Levy et al., 1993; Lehre
et al., 1995; Shibata et al., 1997; Izumi et al., 2002; Slezak et al.,
2007; Ehm et al., 2010), but can also be found in other cell
types, such as pericytes in the spinal cord (Goritz et al., 2011).
Whether GLAST is expressed in cells outside the CNS is not
known, and verifying whether skeletal muscle pericytes express
GLAST would be especially interesting. Supporting this idea,
most GLAST-creER labeled cells in skeletal muscle interstitium
were closely associated with vasculature (Kan et al., 2013). This
study did not specify the cellular origin, but approximately 35%
of the ectopic bone-producing cells in the lesions clearly belong
to a GLAST-expressing lineage. Is a specific pericyte subpopula-
tion responsible? What is its contribution compared to other cell
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types’? The possibility that osteoprogenitor cells might originate
from perivascular cells highlights the strong association between
angiogenesis and the heterotypic ossification of skeletal muscle
(Hegyi et al., 2003).
The basic molecular mechanisms involved in ectopic calcifica-
tion in skeletal muscle are not known. Critical inductive factors
and a permissive environment may affect specific cell types and
contribute to heterotopic ossification (Chalmers et al., 1975;
Baird and Kang, 2009). A recent study suggests that the same
mechanism that induces vascular calcification gives rise to osteo-
progenitor cells (Yao et al., 2013). Elucidating these mechanisms
is important since we have no effective and safe therapy to prevent
this condition. Regulatory molecules acting on the perivascu-
lar cells necessary for the development of traumatic heterotopic
ossification should be further investigated.
The bone morphogenetic proteins (BMP) of ALK2 ligands,
such as BMP2, BMP4, and BMP9, might be primary inducers
of heterotopic ossification; mixed with Matrigel and injected into
the skeletal muscles of mice, they have osteoblastic activity (Chen
et al., 2012; Nishimura et al., 2012), and they are highly expressed
in human lesions with heterotopic ossification (Gannon et al.,
1997; Grenier et al., 2013). Transgenic mouse models of het-
erotopic ossification with specific signaling molecules, such as
BMPs, deleted should be used in different cellular targets to
verify whether those molecules are essential for in vivo ectopic
bone formation in skeletal muscle in physiological conditions.
Future studies should determine whether BMP receptors are
expressed in pericytes. Additionally, the fate of pericyte subtypes
exposed to BMPs should be investigated to determine whether
their differentiation potential remains unchanged after exposure
to BMPR-Fc chimeric receptors, which compete with pericyte
receptors for ligands. Future efforts should focus on the activa-
tion of osteogenic potential by such less-studied molecules as the
growth factor Nell-1, which induces osteogenic differentiation in
pericytes (Zhang et al., 2011). The discovery of such signals and
a better understanding of the exact role of pericytes in skele-
tal muscle ectopic calcification would support development of
therapeutic strategies to treat this clinically significant condition.
CONCLUSIONS
Pericytes play several critical roles in skeletal muscle repair, and
elucidating how their tissue- formation capabilities contribute to
skeletal muscle pathophysiology will be important to future treat-
ments. Based on their molecular markers and specific functions,
muscular pericytes have been identified as heterogeneous, and at
least two subpopulations have been described. Taking their diver-
sity into account, information regarding pericytes will be crucial
in advancing our understanding of skeletal muscle disease and
aging.
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